Gurgaon-based NeuroClub, a first of its kind neuroscience startup, has secured ₹2.7 crores ($400,000) in investments. The funds raised will be used to expand its outreach to other global geographies after its launch in India.
NeuroClub was established in 2018 by Phillip Mertz, a Harvard-trained entrepreneur, along with Dr Sriraman Damodaran, a neuroscientist. The startup will be launching its operations in India on August 17, 2018.
NeuroClub provides brain health products, using natural herbs extracts to enhance the quality of life of its customers. It uses its proprietary Enhanced Absorption formulation mechanism to allow the extracted bioactives to pass the Blood Brain Barrier (BBB) to improve brain functions.
It will be offering a suite of six OTC products to address various cognitive functions and health needs including sustained focus, the ability to store memories longer, stress-management, and protection against negative effects of alcohol. Its flagship products include Xance, Seraxil, Myeliv, Metanine, Enkodin, and Agilin.
Dr Damodaran, co-founder, NeuroCub, said, “The brain is mechanism in the same way that a clock is or other organs in the body. When your clock is broken you can tweak something to make it work properly. When your body is not working properly you can adjust the part that it out of sync so that it operates correctly. The brain is no different. Typically when people can’t focus on their work they don’t think there is something in the brain that they can tweak, but there is.”
With the focus on cognitive enhancement, NeuroClub is looking to tap the Indian market with its all-natural brain health products.
Cognitive enhancement is a globally growing industry. According to the company, in the United States, competitive areas like Silicon Valley and college campuses are filled with people using external remedies to enhance cognitive performance. With India being a country heavily focused on academics, there is a potential for growth in India as academic competition increases.